Evidence map›Paper›PMID 32491038›Full record

ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

DRD4 genotyping may differentiate symptoms of attention-deficit/hyperactivity disorder and sluggish cognitive tempo.

Hilmi Bolat, Eyüp S Ercan, Gül Ünsel-Bolat, Akin Tahillioğlu, Kemal U Yazici, Ali Bacanli, Erhan Pariltay, Duygu Aygüneş Jafari, Buket Kosova, Semiha Özgül and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 33 citations in OpenAlex.

  1. Testing DAT1 and DRD4 Genes in Attention Deficit Hyperactivity Disorder Using a Wide Spectrum of Neurocognitive Batteries.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Attention-deficit/hyperactive disorder updates.Frontiers in molecular neuroscience · 2022
    Review
  7. Brain sciences · 2021
    Article
  8. ADHD: Reviewing the Causes and Evaluating Solutions.Journal of personalized medicine · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Hilmi BolatDepartment of Medical Genetics, Balikesir Atatürk City Hospital, Balikesir, Turkey.ORCID http://orcid.org/0000-0001-6574-8149
Eyüp S ErcanDepartment of Child and Adolescent Psychiatry, Ege University, Izmir, Turkey.
Gül Ünsel-BolatDepartment of Child and Adolescent Psychiatry, Balikesir University Faculty of Medicine, Balikesir, Turkey.
Akin TahillioğluDepartment of Child and Adolescent Psychiatry, Ege University, Izmir, Turkey.
Kemal U YaziciDepartment of Child and Adolescent Psychiatry, Firat University, Izmir, Turkey.
Ali BacanliDepartment of Child and Adolescent Psychiatry, Baskent University, Izmir, Turkey.
Erhan PariltayDepartment of Medical Genetics, Ege University, Izmir, Turkey.
Duygu Aygüneş JafariDepartment of Medical Biology, Ege University, Izmir, Turkey.
Buket KosovaDepartment of Medical Biology, Ege University, Izmir, Turkey.
Semiha ÖzgülDepartment of Bioistatistics and Medical Informatics, Ege University, Izmir, Turkey.
Luis A RohdePrograma de Transtornos de Déficit de Atenção/Hiperatividade (ProDAH), Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Haluk AkinDepartment of Medical Genetics, Ege University, Izmir, Turkey.
Ege University · TRBalıkesir University · TRBaşkent University · TRFırat University · TRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveStudies to reduce the heterogeneity of attention-deficit/hyperactivity disorder (ADHD) have increased interest in the concept of sluggish cognitive tempo (SCT). The aim of this study was to investigate if the prevalence of two variable-number tandem repeats (VNTRs) located within the 3'-untranslated region of the DAT1 gene and in exon 3 of the dopamine D4 receptor (DRD4) gene differ among four groups (31 subjects with SCT but no ADHD, 146 individuals with ADHD but no SCT, 67 subjects with SCT + ADHD, and 92 healthy controls).

methodsWe compared the sociodemographic profiles, neurocognitive domains, and prevalence of two VNTRs in SCT and ADHD subjects versus typically developing (TD) controls.

resultsThe SCT without ADHD group had a higher proportion of females and lower parental educational attainment. Subjects in this group performed worse on neuropsychological tests, except for psychomotor speed and commission errors, compared to controls. However, the ADHD without SCT group performed significantly worse on all neuropsychological domains than controls. We found that 4R homozygosity for the DRD4 gene was most prevalent in the ADHD without SCT group. The SCT without ADHD group had the highest 7R allele frequency, differing significantly from the ADHD without SCT group.

conclusionThe 7R allele of DRD4 gene was found to be significantly more prevalent in SCT cases than in ADHD cases. No substantial neuropsychological differences were found between SCT and ADHD subjects.

Indexed as

Attention Deficit Disorder with HyperactivityCognitionFemaleGenotypeHumansMinisatellite RepeatsReceptors, Dopamine D4DRD4 protein, humanReceptors, Dopamine D4

Identifiers

PMID32491038
PMCPMC7678899
OpenAlexW3031385812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.